RayzeBio (NASDAQ:RYZB) Downgraded to “Market Perform” at William Blair
William Blair lowered shares of RayzeBio (NASDAQ:RYZB – Free Report) from an outperform rating to a market perform rating in a report released on Tuesday, MarketBeat Ratings reports. William Blair also issued estimates for RayzeBio’s FY2023 earnings at ($3.25) EPS, Q2 2024 earnings at ($0.06) EPS, Q3 2024 earnings at ($0.09) EPS, Q4 2024 earnings […]
More Stories
Spartan Delta Corp. (TSE:SDE) Given Average Recommendation of “Buy” by Brokerages
Shares of Spartan Delta Corp. (TSE:SDE – Get Free Report) have been assigned an average recommendation of “Buy” from the...
Mueller Water Products, Inc. (NYSE:MWA) Given Consensus Rating of “Hold” by Brokerages
Shares of Mueller Water Products, Inc. (NYSE:MWA – Get Free Report) have earned a consensus rating of “Hold” from the...
Neurogene Inc. (NASDAQ:NGNE) Receives $51.00 Consensus PT from Analysts
Shares of Neurogene Inc. (NASDAQ:NGNE – Get Free Report) have been given a consensus recommendation of “Buy” by the nine...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Given Average Rating of “Hold” by Brokerages
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) have been given an average recommendation of “Hold” by the...
A.P. Møller – Mærsk A/S (OTCMKTS:AMKBY) Receives Consensus Recommendation of “Reduce” from Brokerages
A.P. Møller – Mærsk A/S (OTCMKTS:AMKBY – Get Free Report) has been assigned an average recommendation of “Reduce” from the...
Middlefield Banc (NASDAQ:MBCN) Upgraded at StockNews.com
StockNews.com upgraded shares of Middlefield Banc (NASDAQ:MBCN – Free Report) from a sell rating to a hold rating in a...